期刊文献+

趋化因子受体1在人结肠癌中的表达及其与肿瘤转移的相关性研究 被引量:12

Expression of CC Chemokine Receptor 1 in Colorectal Carcinoma Tissues and Its Association with Tumor Metastasis
下载PDF
导出
摘要 目的研究趋化因子受体1(CC chemokine receptor 1,CCR1)在人结肠癌组织中的表达分布情况,探讨其表达水平与临床病理特征的关系。方法收集广州军区武汉总医院普通外科手术切除并经病理诊断证实的96例结肠癌组织。采用Real-time PCR、Western blot及免疫组化技术检测CCR1在96例结肠癌组织及相应的癌旁组织中的表达分布情况,并分析其表达差异与结肠癌淋巴结转移及肝转移的相关性。结果在96例结肠癌组织及其相应的癌旁组织中均可检测到CCR1的表达,结肠癌组织中的表达水平明显高于癌旁组织。CCR1mRNA表达水平与患者性别、年龄、肿瘤大小无明显相关性(均P〉0.05),而与肿瘤的淋巴结转移、远处转移及TNM分期显著相关(均P〈0.05)。免疫组化检测结果显示CCR1在结肠癌组织中的蛋白表达主要定位于细胞膜。26例淋巴转移的结肠癌组织中,10例(38.5%)染色强度为++-+++,16例淋巴结转移合并肝转移的结肠癌组织中,13例(81.2%)染色强度为++-+++,经χ^2检验,两组比较差异具有统计学意义(χ^2=6.095,P=0.014)。结论 CCR1在结肠癌组织中的表达高于癌旁组织,其表达水平与淋巴结转移及肝转移相关,具有一定的诊断价值,有望成为判断结肠癌侵袭转移能力及预后的指标。 Objective To investigate the expression of CC chemokine receptor 1(CCR1)in the human colorectal carcinoma and its correlation with clinicopathological characteristics of colorectal carcinoma.Methods A total of 96 colorectal carcinoma tissues and their adjacent normal tissues were surgically removed and pathologically confirmed in our hospital.Real-time PCR,Western blot and immunohistochemistry were used to examine the expression and distribution of CCR1 in these tissues.Moreover,the association of the expression of CCR1 with lymph nodes metastasis and liver metastasis was analyzed.Results CCR1 was found to express at mRNA and protein levels in 96 colorectal carcinoma tissues and their adjacent normal tissues,with the expression level significantly higher in cancer tissues than in adjacent normal tissues(P〈0.05).The expression of CCR1 mRNA was significantly correlated with lymph nodes metastasis,remote metastasis and TNM stage(P〈0.05 for all),but not with gender,age and tumor size.In addition,immunohistochemistry revealed that CCR1 protein was mainly located on the membrane of colorectal carcinoma cells.Moreover,the moderate to strong staining of CCR1 protein was found in81.2%of colorectal carcinomas with lymph nodes metastasis and liver metastasis,which was markedly higher than in 38.5%of colorectal carcinomas with only lymph nodes metastasis(χ^2=6.095,P=0.014).Conclusion The expression of CCR1 is greater in colorectal cancer than in adjacent normal tissues.CCR1 expression levels are correlated with lymph nodes metastasis and liver metastasis,which is of clinical value.CCR1 may serve as a potential marker to evaluate the metastasis of colorectal carcinoma and the prognosis of patients.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2014年第4期427-430,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 结肠癌 趋化因子受体1 淋巴结转移 肝转移 colorectal carcinoma CC chemokine receptor 1 lymph nodes metastasis liver metastasis
  • 相关文献

参考文献14

  • 1Kin B N, Yamamoto H, Ikeda K, et al. Methylation and ex- pression of P16 NK4 tumor suppressor gone in primary color- ectal cancer tissues[J]. Int J Oncol,2005,26(5) :1217-1226.
  • 2Kitamura T, Fujishita T, Loetscher P, et al. Inactivation of chemokinc(C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model[J]. Proc Natl Acad Sci USA, 2010,107(29) : 13063-13068.
  • 3Krohn N, Kapoor S, Enami Y, et al. Hepatocyte transplanta tion induced liver inflammation is driven by eytokines-ehemo- kines associated with neutrophils and Kupffer cells[J]. Gas- troenterology, 2009,136 (5) :1806-1817.
  • 4Koizumi K, Hojo S, Akashi T, et al. Chemokine receptors in cancer metastasis and cancer cell-derived ehemokines in host immune response[-J]. Cancer Sci,2007,98(11) : 1652-1658.
  • 5Silva T A,Ribeiro F L,Oliveira-Neto H H,et al. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: Implications in tumormetastasis and local host derense[J]. Oncol Rep, 2007, 18(5) : 1107-1113.
  • 6Balkwill F. Cancer and the chemokine network[J]. Nat Rev Cancer, 2004,4(7) :540-550.
  • 7Muller A, Homey B,Soto H, et al. Involvement of ehemokine receptors in breast cancer metastasis[J]. Nature, 2001,410 (6824):50-56.
  • 8Balkwill F. Chemokine biology in cancer[J]. Semin Immunol, 2003,15(1) :49-55.
  • 9Murphy P M. Chemokines and the molecular basis of cancer metastasis[J]. N Engl J Med,2001,345(11) :833-835.
  • 10马进安,邱振华,裴海平.趋化因子受体CCR1在人大肠癌组织中的表达及其与淋巴结转移的相关性[J].细胞与分子免疫学杂志,2009,25(8):714-715. 被引量:4

二级参考文献25

  • 1程变巧,龚伟,耿炎,陈琳,武金宝,姜泊.Galectin-3在不同病理分期大肠癌中的差异表达研究[J].中国现代医学杂志,2007,17(13):1585-1587. 被引量:4
  • 2Lovet JM,Burroughs A,Bruix J.Hepatocellular carcinoma.Lancet,2003,362:1907-1917.
  • 3Okuda K.Hepatocellular carcinoma.clinicopathological aspects.J Gastroenterol Hepatol,1997,12:S314-S318.
  • 4Balkwill F.Chemokine biology in cancer.Semin Immunol,2003,15:49-55.
  • 5Murphy PM.Chemokines and the molecular basis of cancer metastasis.N Eng J Med,2001,345:833-835.
  • 6Devora-Rossi AZ.The biology of chemokines and their receptors.Annu Rev Immunol,2000,18:217-242.
  • 7Schwarz MK,Wells TN.New therapeutics that modulate chemokine networks.Nat Rev Drug Discov,2002,1:347-358.
  • 8Muller A,Homey B,Soto H,et al.Involvement of chemokine receptors in breast cancer metastasis.Nature,2001,410:50-56.
  • 9Kuwada Y,Sasaki T,Morinaka K,et al.Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.Int J Oncol,2003,22:765-771.
  • 10Cardones AR,Murakami T,Hwang ST,et al.CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrir.Cancer Res,2003,63:6751-6757.

共引文献25

同被引文献85

  • 1朱虹,陈孝平.原发性肝癌转移和复发的分子机制及治疗的研究进展[J].中华肝胆外科杂志,2004,10(1):68-70. 被引量:9
  • 2曾林,孙岩松,胡仲明.肝癌转移机制的研究进展[J].实用医药杂志,2006,23(1):101-103. 被引量:3
  • 3王晓颖,樊嘉,周俭,邱双健,余耀,刘银坤,汤钊猷.CCR1趋化因子受体在人肝癌组织中表达及其临床意义[J].中华肝胆外科杂志,2006,12(2):101-104. 被引量:20
  • 4李冬梅,赵秀媛,朱传金,刘美芹.M_2-PK与CEA、CA19-9、CA72-4对消化系统肿瘤诊断的比较分析[J].临床消化病杂志,2007,19(1):53-55. 被引量:8
  • 5Boncheva V, Bonney S A, Brooks S E, et al.New targets for the immunotherapy of colon cancer does reactive disease hold the answer[J]. Cancer Gene Ther, 2013, 20(3): 157-168.
  • 6Meylan E, Tschopp J.The RIP kinases: crucial integrators of cellular stress[J].TrendsBiochemSci, 2005, 30(3): 151-159.
  • 7Festjens N, Vanden Berghe T, Come/is S, et al.RIP1, a kinase on the crossroads of a cell's decision to live or die[J].Cell Death Differ, 2007, 14(3) : 400-410.
  • 8Peter L, Natalle R, Katsuyukl T, et al.Suppression of apoptosis in mammalian ceils by NAPI and a related family of IAP genes[J].Nature, 1996, 379(15): 349-353.
  • 9Kim H, Kataru RP, Koh GY. Regulation and implications of inflammatory lymphangiogenesis [ J ]. Trends Immunol, 2012,33(7) :350-356.
  • 10Sheng KC, Wright MD, Apostolopoulos V. Inflammatory mediators hold the key to dendritie eell suppression and tumor progression [J]. Curt Med Chem,2011 ,18(36) :5507-5518.

引证文献12

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部